49 related articles for article (PubMed ID: 11949840)
1. Significance of P-glycoprotein expression in childhood malignant tumors.
Kucerová H; Sumerauer D; Drahokoupilová E; Pisková M; Bedrnícek J; Eckschlager T
Neoplasma; 2001; 48(6):472-8. PubMed ID: 11949840
[TBL] [Abstract][Full Text] [Related]
2. Multidrug drug resistance in pediatric sarcomas.
Chan HS; DeBoer G; Haddad G; Ling V
Hematol Oncol Clin North Am; 1995 Aug; 9(4):889-908. PubMed ID: 7490247
[TBL] [Abstract][Full Text] [Related]
3. Expression of P-glycoprotein in normal muscle cells and myogenic tumors.
Garberoglio C; Dudas M; Casper ES; Bertino J; Cordon-Cardo C
Arch Pathol Lab Med; 1992 Oct; 116(10):1055-61. PubMed ID: 1384456
[TBL] [Abstract][Full Text] [Related]
4. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
[TBL] [Abstract][Full Text] [Related]
5. Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
Camassei FD; Arancia G; Cianfriglia M; Bosman C; Francalanci P; Ravà L; Jenkner A; Donfrancesco A; Boldrini R
Am J Clin Pathol; 2002 Mar; 117(3):484-90. PubMed ID: 11888090
[TBL] [Abstract][Full Text] [Related]
6. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
Harms D
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
[TBL] [Abstract][Full Text] [Related]
7. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.
Schwartz CL; Gorlick R; Teot L; Krailo M; Chen Z; Goorin A; Grier HE; Bernstein ML; Meyers P;
J Clin Oncol; 2007 May; 25(15):2057-62. PubMed ID: 17513810
[TBL] [Abstract][Full Text] [Related]
8. The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia.
De Moerloose B; Swerts K; Benoit Y; Laureys G; Loeys T; Philippé J; Dhooge C
Pediatr Hematol Oncol; 2003; 20(5):381-91. PubMed ID: 12775536
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance-related markers in primary neuroblastoma.
Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
[TBL] [Abstract][Full Text] [Related]
11. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors.
Matsumine A; Shintani K; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Iino T; Uchida A
J Surg Oncol; 2007 Oct; 96(5):411-8. PubMed ID: 17579351
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.
Penson RT; Oliva E; Skates SJ; Glyptis T; Fuller AF; Goodman A; Seiden MV
Gynecol Oncol; 2004 Apr; 93(1):98-106. PubMed ID: 15047220
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
16. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
[TBL] [Abstract][Full Text] [Related]
17. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in the expression of markers for drug resistance in brain tumors.
Andersson U; Malmer B; Bergenheim AT; Brännström T; Henriksson R
Clin Neuropathol; 2004; 23(1):21-7. PubMed ID: 14986930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
